The relative importance of the ADP receptors, P2Y12 and P2Y 1, in thrombin-induced platelet activation

Thrombosis Research

Volumn 111, Issue 1-2, 2003, Pages 65-73

  Nylander, Sven ^a   Mattsson, Christer ^a   Ramström, Sofia ^b   Lindahl, Tomas L ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ADP; Flow cytometry; P2Y12; P2Y1; Platelets; Thrombin

Indexed keywords

ADENOSINE DIPHOSPHATE; AR C69931; FIBRINOGEN RECEPTOR; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBUNIT; THROMBIN;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONFORMATION; CONTROLLED STUDY; DRUG TARGETING; FLOW CYTOMETRY; HUMAN; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

EID: 0345603731     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.08.021     Document Type: Article

References (31)

1. Vu T.K., Hung D.T., Wheaton V.I., Coughlin S.R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1991;1057-1068.
2. Ishihara H., Connolly A.J., Zeng D., Kahn M.L., Zheng Y.W., Timmons C., et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 386:1997;502-506.
3. Xu W.F., Andersen H., Whitmore T.E., Presnell S.R., Yee D.P., Ching A., et al. Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6642-6646.
4. Kahn M.L., Nakanishi-Matsui M., Shapiro M.J., Ishihara H., Coughlin S.R. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest. 103:1999;879-887.
5. Covic L., Gresser A.L., Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry. 39:2000;5458-5467.
6. Ayala Y.M., Cantwell A.M., Rose T., Bush L.A., Arosio D., Di Cera E. Molecular mapping of thrombin-receptor interactions. Proteins Struct. Funct. Genet. 45:2001;107-116.
7. Jin J., Daniel J.L., Kunapuli S.P. Molecular basis for ADP-induced platelet activation: II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J. Biol. Chem. 273:1998;2030-2034.
8. Hollopeter G., Jantzen H.M., Vincent D., Li G., England L., Ramakrishnan V., et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. 409:2001;202-207.
9. Zhang F.L., Luo L., Gustafson E., Lachowicz J., Smith M., Qiao X.D., et al. ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J. Biol. Chem. 276:2001;8608-8615.
10. Dangelmaier C., Jin J., Smith J.B., Kunapuli S.P. Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway. Thromb. Haemost. 85:2001;341-348.
11. Kauffenstein G., Bergmeier W., Eckly A., Ohlmann P., Leon C., Cazenave J.P., et al. The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin-a phosphoinositide 3-kinase-dependent mechanism. FEBS Lett. 505:2001;281-290.
12. Jin J., Kunapuli S.P. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8070-8074.
13. Eckly A., Gendrault J.L., Hechler B., Cazenave J.P., Gachet C. Differential involvement of the P2Y(1) and P2Y(T) receptors in the morphological changes of platelet aggregation. Thromb. Haemost. 85:2001;694-701.
14. Leon C., Hechler B., Freund M., Eckly A., Vial C., Ohlmann P., et al. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J. Clin. Invest. 104:1999;1731-1737.
15. Foster C.J., Prosser D.M., Agans J.M., Zhai Y., Smith M.D., Lachowicz J.E., et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J. Clin. Invest. 107:2001;1591-1598.
16. Nurden P., Savi P., Heilmann E., Bihour C., Herbert J.M., Maffrand J.P., et al. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. J. Clin. Invest. 95:1995;1612-1622.
17. Cattaneo M., Lecchi A., Randi A.M., McGregor J.L., Mannucci P.M. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood. 80:1992;2787-2796.
18. Cattaneo M., Zighetti M.L., Lombardi R., Martinez C., Lecchi A., Conley P.B., et al. Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding. Proc. Natl. Acad. Sci. U. S. A. 100:2003;1978-1983.
19. Cattaneo M., Lecchi A., Lombardi R., Gachet C., Zighetti M.L. Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors. Arterioscler. Thromb. Vasc. Biol. 20:2000;101-116.
20. i signaling. Blood. 99:2002;3629-3636.
21. Baurand A., Raboisson P., Freund M., Leon C., Cazenave J.P., Bourguignon J.J., et al. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur. J. Pharmacol. 412:2001;213-221.
22. Humphries R.G., Tomlinson W., Ingall A.H., Cage P.A., Leff P. FPL 66096: a novel, highly potent and selective antagonist at human platelet P(2T)-purinoceptors. Br. J. Pharmacol. 113:1994;1057-1063.
23. Phillips D.R., Charo I.F., Parise L.V., Fitzgerald L.A. The platelet membrane glycoprotein IIb-IIIa complex. Blood. 71:1988;831-843.
24. Shattil S.J., Hoxie J.A., Cunningham M., Brass L.F. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J. Biol. Chem. 260:1985;11107-11114.
25. Shattil S.J., Cunningham M., Hoxie J.A. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 70:1987;307-315.
26. Michelson A.D. Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical applications. Blood Coagul. Fibrinolysis. 5:1994;121-131.
27. Fox S.C., Burgess-Wilson M., Heptinstall S., Mitchell J.R. Platelet aggregation in whole blood determined using the Ultra-Flo 100 platelet counter. Thromb. Haemost. 48:1982;327-329.
28. Storey R.F., Heptinstall S. Laboratory investigation of platelet function. Clin. Lab. Haematol. 21:1999;317-329.
29. Harrison P., Ault K.A., Chapman S., Charie L., Davis B., Fujimoto K., et al. An interlaboratory study of a candidate reference method for platelet counting. Am. J. Clin. Pathol. 115:2001;448-459.
30. Covic L., Singh C., Smith H., Kuliopulos A. Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak Syndrome. Thromb. Haemost. 87:2002;722-727.
31. Nylander S., Mattsson C. Thrombin-induced platelet activation and its inhibition by anticoagulants with different modes of action. Blood Coagul. Fibrinolysis. 14:2003;159-167.